LifeVantage’s analyst price target has been reset around a model fair value of US$8.00, with the latest work keeping that headline number steady even as several underlying assumptions shift slightly.

SALT LAKE CITY, Oct. 29, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the ...

SALT LAKE CITY, Feb. 04, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation® (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health at the cellular level ...

SALT LAKE CITY, Feb. 04, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the ...

Lifevantage (LFVN) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of ...

Company history teeming with curious events and business model shifts. Products have questionable benefit and their creators have colorful pasts. Despite marketing materials that promote visions of ...

Steven Fife, President and CEO, stated the company is "pleased with our fourth quarter results, including continued growth and improving margins." He reported that revenues grew approximately 13% year ...

Ideally, your overall portfolio should beat the market average. But in any portfolio, there will be mixed results between individual stocks. So we wouldn't blame long term LifeVantage Corporation ...

LifeVantage expands its MindBody GLP-1 System™ internationally after notable U.S. revenue growth, targeting holistic wellness and metabolic health. LifeVantage Corporation is expanding its MindBody ...

LifeVantage reported revenue growth of 12.6% in Q4 and a 21.4% year-over-year increase in adjusted EPS in Q4. International markets returned to growth for the first time in nearly three years during ...